Abstract | BACKGROUND: OBJECTIVE: This study was initiated to help determine the optimal test preparation for MDBGN and to help determine the clinical relevance of such a contact allergy. METHOD: In 38 patients with positive (32 patients) or doubtful (6 patients) patch-test reactions to at least one of four test preparations of MDBGN in petrolatum at 1.0%, 0.5%, 0.3%, and 0.1% (all weight per weight [w/w]), a repeated open application test (ROAT) with moisturizers with and without MDBGN at 0.03% w/w was conducted on patients' upper arms for a maximum of 4 weeks. Seven patients not hypersensitive to MDBGN served as controls and went through the same procedure. RESULTS: Nineteen (59.4%) of the 32 MDBGN-allergic patients developed a positive ROAT result on the arm on which the moisturizer containing MDBGN was applied whereas no patients with doubtful or negative reactions to MDBGN reacted (p = .002). A statistically significant association was found between the patch-test reactivity and the outcome of the ROAT (p < .001). CONCLUSION: Patch testing with MDBGN at 0.3% and 0.1% will miss clinically relevant patch-test reactions to MDBGN.
|
Authors | Marléne Isaksson, Birgitta Gruvberger, Magnus Bruze |
Journal | Dermatitis : contact, atopic, occupational, drug
(Dermatitis)
Vol. 18
Issue 4
Pg. 203-7
(Dec 2007)
ISSN: 1710-3568 [Print] United States |
PMID | 18021599
(Publication Type: Controlled Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Allergens
- Cosmetics
- Nitriles
- 1,2-dibromo-2,4-dicyanobutane
|
Topics |
- Allergens
- Cosmetics
- Dermatitis, Allergic Contact
(diagnosis, etiology)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Humans
- Nitriles
- Patch Tests
(methods)
- Research Design
|